Novoron develops therapeutics for conditions related to damaged CNS. Novoron Bioscience is a biotechnology company focused on advancing a pipeline of biologic therapeutics for spinal cord injury, multiple sclerosis and glaucoma and is part of the JLABS innovation community.
Novoron Bioscience , Inc.
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/novoron-bioscience” connections=”true” suffix=””]
In Dec 2015, Novoron received $680,000 NIH SBIR grant to expand its preclinical work to evaluate new treatments for Multiple Sclerosis Also in past, has received five more NIH grants, totaling more than $1.2 Mn for neurological disorders.